© Copyright by HealthHelpZone.com. All rights reserved.
LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its second quarter 2024 financial results on Thursday, August 8, 2024 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are... ❯❯❯
Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriti... ❯❯❯
DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is proud to announce a strategic partnership between Dallas College and Panthera BioSolutions, a Pharmaceutical/Biotech Services company, to offer a Pharmaceutical GMP Foundational Course. The initiative is part of the ongoing EDA Good Jobs Challenge Biotech grant, which equips students with hands-on fast track... ❯❯❯
Toronto, July 15, 2024 (GLOBE NEWSWIRE) -- LifeLabs has once again been named one of Canada's Best Employers for Diversity by Forbes. This is the third consecutive year LifeLabs has received this recognition. Forbes and Statista, the world-leading statistics portal and industry ranking provider, presents this prestigious award. The awards list was announced on July 9th, 2024, and can be viewed on the Forbes website. The Best... ❯❯❯
MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of July 2024, representing $0.936 per Common Share on an annualized basis. The dividend will be payable on August 15, 2024 to shareholders of record as at July 31, 2024. The Company's dividends are... ❯❯❯
MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of July 2024, which is payable on August 15, 2024 to shareholders of record at the close of business on July 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the... ❯❯❯
Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriti... ❯❯❯
Beijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase its shares of common stock. All of the shares of common stock and pre-funded warrants and the shares of common stock... ❯❯❯
EAGLE, Idaho, July 11, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it has entered into asset purchase agreements to acquire assets of certain affiliates of Signature Healthcare at Home (“Signature”) for a combined purchase price of $80,000,000. Signature is a key provider of home health... ❯❯❯
NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that the Company plans to acquire a majority of Japan Gene Medicine Corporation (the “Target Company”). On June 30, 2024, the Company entered into a share transfer agreement (the "Share Transfer Agreement") to acquire 70.0% of the shares of the Target Company from an individual shareholder. The... ❯❯❯